Works matching IS 20734468 AND DT 2023 AND VI 12 AND IP 1
Results: 25
Cutaneous Lymphoma and Antibody-Directed Therapies.
- Published in:
- Antibodies (2073-4468), 2023, v. 12, n. 1, p. 21, doi. 10.3390/antib12010021
- By:
- Publication type:
- Article
New Insights into Pathogenesis and Treatment of ANCA-Associated Vasculitis: Autoantibodies and Beyond.
- Published in:
- Antibodies (2073-4468), 2023, v. 12, n. 1, p. 25, doi. 10.3390/antib12010025
- By:
- Publication type:
- Article
Intracellular Antibodies for Drug Discovery and as Drugs of the Future.
- Published in:
- Antibodies (2073-4468), 2023, v. 12, n. 1, p. 24, doi. 10.3390/antib12010024
- By:
- Publication type:
- Article
Defensin Interactions in Relation to Monoclonal and Disease-Related Proteinase 3 Antibodies Binding at the Catalytic Site.
- Published in:
- Antibodies (2073-4468), 2023, v. 12, n. 1, p. 23, doi. 10.3390/antib12010023
- By:
- Publication type:
- Article
Safety, Tolerability, and Immunogenicity of V160, a Conditionally Replication-Defective Cytomegalovirus Vaccine, in Healthy Japanese Men in a Randomized, Controlled Phase 1 Study.
- Published in:
- Antibodies (2073-4468), 2023, v. 12, n. 1, p. 22, doi. 10.3390/antib12010022
- By:
- Publication type:
- Article
Intravenous Immunoglobulins as Immunomodulators in Autoimmune Diseases and Reproductive Medicine.
- Published in:
- Antibodies (2073-4468), 2023, v. 12, n. 1, p. 20, doi. 10.3390/antib12010020
- By:
- Publication type:
- Article
Pilot Study Results on Antibodies to the S- and N-Proteins of SARS-CoV-2 in Paired Sera from COVID-19 Patients with Varying Severity.
- Published in:
- Antibodies (2073-4468), 2023, v. 12, n. 1, p. 19, doi. 10.3390/antib12010019
- By:
- Publication type:
- Article
Serological Cross-Reactivity in Zoonotic Flaviviral Infections of Medical Importance.
- Published in:
- Antibodies (2073-4468), 2023, v. 12, n. 1, p. 18, doi. 10.3390/antib12010018
- By:
- Publication type:
- Article
Comparative Binding Ability of Human Monoclonal Antibodies against Omicron Variants of SARS-CoV-2: An In Silico Investigation.
- Published in:
- Antibodies (2073-4468), 2023, v. 12, n. 1, p. 17, doi. 10.3390/antib12010017
- By:
- Publication type:
- Article
Bioprocess Development and Characterization of a 13 C-Labeled Hybrid Bispecific Antibody Produced in Escherichia coli.
- Published in:
- Antibodies (2073-4468), 2023, v. 12, n. 1, p. 16, doi. 10.3390/antib12010016
- By:
- Publication type:
- Article
Non-Affinity Purification of Antibodies.
- Published in:
- Antibodies (2073-4468), 2023, v. 12, n. 1, p. 15, doi. 10.3390/antib12010015
- By:
- Publication type:
- Article
Characterization of an IDH1 R132H Rabbit Monoclonal Antibody, MRQ-67, and Its Applications in the Identification of Diffuse Gliomas.
- Published in:
- Antibodies (2073-4468), 2023, v. 12, n. 1, p. 14, doi. 10.3390/antib12010014
- By:
- Publication type:
- Article
Anti-RuvBL1/2 Autoantibodies Detection in a Patient with Overlap Systemic Sclerosis and Polymyositis.
- Published in:
- Antibodies (2073-4468), 2023, v. 12, n. 1, p. 13, doi. 10.3390/antib12010013
- By:
- Publication type:
- Article
Antibodies, B Cell Responses and Immune Responses to SARS-CoV-2 Infections.
- Published in:
- Antibodies (2073-4468), 2023, v. 12, n. 1, p. 12, doi. 10.3390/antib12010012
- By:
- Publication type:
- Article
Determination of the Binding Epitope of an Anti-Mouse CCR9 Monoclonal Antibody (C 9 Mab-24) Using the 1× Alanine and 2× Alanine-Substitution Method.
- Published in:
- Antibodies (2073-4468), 2023, v. 12, n. 1, p. 11, doi. 10.3390/antib12010011
- By:
- Publication type:
- Article
Rapidly Progressive Pauci-Immune Glomerulonephritis with Aberrant Fibrinoid Necrosis Associated with Atezolizumab, an Immune Check Point Inhibitor: A Case Report and Review of Literature.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Characterization of Active MMP9 in Chronic Inflammatory Diseases Using a Novel Anti-MMP9 Antibody.
- Published in:
- Antibodies (2073-4468), 2023, v. 12, n. 1, p. 9, doi. 10.3390/antib12010009
- By:
- Publication type:
- Article
Acknowledgment to the Reviewers of Antibodies in 2022.
- Published in:
- Antibodies (2073-4468), 2023, v. 12, n. 1, p. 8, doi. 10.3390/antib12010008
- Publication type:
- Article
Therapeutic Phage Display-Derived Single-Domain Antibodies for Pandemic Preparedness.
- Published in:
- Antibodies (2073-4468), 2023, v. 12, n. 1, p. 7, doi. 10.3390/antib12010007
- By:
- Publication type:
- Article
Design, Production, Characterization, and Use of Peptide Antibodies.
- Published in:
- Antibodies (2073-4468), 2023, v. 12, n. 1, p. 6, doi. 10.3390/antib12010006
- By:
- Publication type:
- Article
A Review of the Currently Available Antibody Therapy for the Treatment of Coronavirus Disease 2019 (COVID-19).
- Published in:
- Antibodies (2073-4468), 2023, v. 12, n. 1, p. 5, doi. 10.3390/antib12010005
- By:
- Publication type:
- Article
TLR7 and IgM: Dangerous Partners in Autoimmunity.
- Published in:
- Antibodies (2073-4468), 2023, v. 12, n. 1, p. 4, doi. 10.3390/antib12010004
- By:
- Publication type:
- Article
Specific Autoantibodies and Microvascular Damage Progression Assessed by Nailfold Videocapillaroscopy in Systemic Sclerosis: Are There Peculiar Associations? An Update.
- Published in:
- Antibodies (2073-4468), 2023, v. 12, n. 1, p. 3, doi. 10.3390/antib12010003
- By:
- Publication type:
- Article
The Seroprevalence and Seropositivity of SARS-CoV-2 among Healthcare Workers during the Third Pandemic Wave.
- Published in:
- Antibodies (2073-4468), 2023, v. 12, n. 1, p. 2, doi. 10.3390/antib12010002
- By:
- Publication type:
- Article
Philosophical Approach to Neural Autoantibodies in Psychiatric Disease—Multi-Systemic Dynamic Continuum from Protective to Harmful Autoimmunity in Neuronal Systems.
- Published in:
- Antibodies (2073-4468), 2023, v. 12, n. 1, p. 1, doi. 10.3390/antib12010001
- By:
- Publication type:
- Article